Early Life
Park Soon-jae was born on December 22, 1954, in Gunsan, South Korea. He graduated from Seoul High School in 1973. He then went on to earn a bachelor's degree in biochemistry from Yonsei University in 1980. Park furthered his education in the United States, obtaining a Ph.D. in biochemistry from Purdue University in 1985.
Rise to Success
Park's career began with research positions, including a stint at the Massachusetts Institute of Technology (MIT) from 1986 to 1988. He gained experience in various biotechnology research roles in South Korea starting in 1988. In 1998, he became head of development at LG Chem. In 2006, he became managing director of Dream Pharma. In 2008, Park co-founded Alteogen with his wife, Chung Hye-shin. The company focused on biosimilars and bio-betters. Alteogen's ALT-B4 technology, which allows drugs to be administered subcutaneously, is a key innovation. A significant milestone was reached in 2024 when Merck agreed to a licensing deal to use ALT-B4 for its cancer drug pembrolizumab. This deal boosted Park's net worth substantially.
Key Business Strategies
Park's business strategy has been marked by a focus on core competencies and innovation. Alteogen's success is partly due to its proprietary ALT-B4 technology. His leadership emphasized focusing on core strengths and identifying opportunities within the biopharmaceutical market. He focused on developing new biosimilars and biobetters to make Alteogen a global player.
Philanthropy
I am sorry, but I am unable to find any specific philanthropic amounts or initiatives associated with Park Soon-jae.
